Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2026 10:15 ET | Source: Exousia Pro, Inc.

Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value

OTC.MAJI Announces landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value.
March 16, 2026 08:00 ET | Source: Cytokinetics, Incorporated

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten) SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) --...
March 16, 2026 07:20 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
March 13, 2026 11:29 ET | Source: ProText Mobility, Inc.

ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases

ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases
March 12, 2026 16:05 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal...
March 12, 2026 11:55 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Joint Venture Terms and Agreement Analysis Report 2026: Valuable Insights Into Deal Structures, Financial Terms, and Partnership Strategies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026" report has been added to ResearchAndMarkets.com's offering.The Joint Venture...
March 12, 2026 11:46 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Asset Purchase Agreements Report 2026 and Directory of Deals Signed Since 2019 by the World's Leading Life Science Companies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering.The Asset Purchase...
March 12, 2026 11:27 ET | Source: Research and Markets

Biotechnology Collaboration Agreements Report 2026 with Directory of 2,000+ Deals Signed Since 2020 - Access Real Contract Documents and Identify the Most Active Dealmakers

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering.The Collaboration Deals in Biotechnology...
March 12, 2026 10:54 ET | Source: Research and Markets

Biotechnology Licensing Agreements Trends Report 2026 with Directory of 2,500+ Deals Signed Since 2020 by the World's Leading Biopharma Companies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Licensing Deals in Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering.The Licensing Deals in Biotechnology 2020-2026...
March 12, 2026 10:41 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Agreements Trends Report 2026 with Directory of 384 Deal Records - Terms, Structures, and Strategies Behind These Impactful Partnerships

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2026" report has been added to ResearchAndMarkets.com's offering. Whether...